Real-world multicenter study of the safety and efficacy of netupitant plus palonosetron fixed-dose combination to prevent chemotherapy-induced nausea and vomiting among Malaysian patients receiving moderately or highly emetogenic chemotherapy.
Mastura Md YusofMatin Mellor AbdullahBeng Khiong YapSoo Chin NgJohn Seng Hooi LowKai Seng LamRadzi Bin Ahmad Ahmad BadruddinChristina Nye Bing LaiKah Liew LauKwang Jeat ChongJoel Gabriel NonisMuhammad Azrif Ahmad AnnuarMohd Haris Fadzillah Bin Abdul RahmanPublished in: Asia-Pacific journal of clinical oncology (2021)
NEPA had sustained efficacy and tolerability at first administration and across two cycles of MEC/HEC for CINV prevention.